ICG-001 is a potent β-catenin/CBP inhibitor. It blocks Wnt/β-catenin signaling by disrupting the protein-protein interaction between β-catenin and CBP, effectively inhibiting cancer cell proliferation, migration, and tissue fibrosis.
ICG-001: Mechanism of Action
ICG-001 MOA：Targeting CBP/Wnt/β-catenin signaling pathway for Oncology
Jump to
- ICG-001: Selectivity & Specificity
- ICG-001 Working Concentration | Cell Culture | Treatment
- ICG-001 Solubility in DMSO
- ICG-001 Stock Solution
- ICG-001 Storage
- ICG-001 Stability
- ICG-001 Combination Database
- ICG-001 Molecular Weight
- ICG-001 SMILES
- ICG-001 CAS Number
- ICG-001 Chemical Structure (2D and 3D)
- ICG-001 IC50 for Cell-based and Cell-free Assays
- ICG-001 Sigma (504712)? Try a better option.
- ICG-001 Tocris (4505)? Try a better option.
- ICG-001 MedChemExpress (HY-14428)? Try a better option.
- ICG-001 SDS｜MSDS